Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESWT and PRP for Rotator Cuff Calcific Tendinitis
NCT06372600Not yet recruiting
- Start
- Jun 2025
- Primary completion
- Dec 2025
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
01
Overview
Randomised, single-blind trial of platelet-rich plasma in rotator cuff calcific tendinopathy (RCCT) (3 arms). Primary endpoint: Visual Analogue Scale at 8 weeks. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
rotator cuff calcific tendinopathy (RCCT)
Beyond the preview
Go deeper on NCT06372600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06372600.